Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

Noriyuki Nakatsu, Tomoki Nakamura, Kanami Yamazaki, Soutaro Sadahiro, Hiroyasu Makuuchi, Jun Kanno and Takao Yamori
Molecular Pharmacology November 2007, 72 (5) 1171-1180; DOI: https://doi.org/10.1124/mol.107.038836
Noriyuki Nakatsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tomoki Nakamura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kanami Yamazaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Soutaro Sadahiro
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hiroyasu Makuuchi
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Kanno
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takao Yamori
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 72 no. 5 1171-1180
DOI 
https://doi.org/10.1124/mol.107.038836
PubMed 
17702889

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Received June 6, 2007
  • Accepted August 16, 2007
  • Published online October 23, 2007.

Article Versions

  • Earlier version (August 16, 2007 - 08:45).
  • You are viewing the most recent version of this article.
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Noriyuki Nakatsu,
  2. Tomoki Nakamura,
  3. Kanami Yamazaki,
  4. Soutaro Sadahiro,
  5. Hiroyasu Makuuchi,
  6. Jun Kanno and
  7. Takao Yamori
  1. Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan (N.N., T.N., K.Y., T.Y.); Division of Cellular and Molecular Toxicology, Biological Safety Research Center, National Institute of Health Sciences, Setagaya-ku, Tokyo, Japan (N.N., J.K.); and Second Department of Surgery, Tokai University School of Medicine, Boseidai, Isehara-City, Kanagawa, Japan (T.N., S.S., H.M.)
  1. Address correspondence to:
    Takao Yamori, Division of Molecular Pharmacology, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-10-6, Ariake, Koto-ku, Tokyo 135-8550, Japan. E-mail: yamori{at}jfcr.or.jp, 07a$sl
View Full Text

Statistics from Altmetric.com

Article usage

Article usage: August 2007 to March 2023

AbstractFullPdf
Aug 200717078
Sep 200717029
Oct 200720443
Nov 2007311316
Dec 200718107
Jan 200826811
Feb 200828710
Mar 20083158
Apr 200834916
May 20082766
Jun 200832720
Jul 200839613
Aug 200845518
Sep 200832614
Oct 200859723
Nov 2008292341
Dec 2008142019
Jan 2009182140
Feb 2009123425
Mar 2009193124
Apr 200971834
May 2009112331
Jun 2009101841
Jul 2009111027
Aug 200961715
Sep 2009122121
Oct 2009191424
Nov 2009132119
Dec 2009132326
Jan 2010162023
Feb 2010153027
Mar 2010132414
Apr 201092612
May 2010112915
Jun 2010283029
Jul 2010283730
Aug 2010222717
Sep 2010141726
Oct 2010182922
Nov 2010232928
Dec 201017917
Jan 2011131320
Feb 2011112027
Mar 2011142919
Apr 2011151912
May 201110915
Jun 2011121514
Jul 2011182253
Aug 2011162020
Sep 2011183520
Oct 2011154318
Nov 2011193421
Dec 2011202416
Jan 2012403131
Feb 2012132826
Mar 2012192921
Apr 201292315
May 2012204322
Jun 2012152217
Jul 2012152832
Aug 2012272116
Sep 201220219
Oct 2012181820
Nov 2012152614
Dec 2012132418
Jan 2013374015
Feb 2013112315
Mar 2013163730
Apr 2013133031
May 2013202015
Jun 2013162112
Jul 2013131911
Aug 2013785
Sep 2013131710
Oct 2013163417
Nov 2013262313
Dec 20136614
Jan 201451515
Feb 201451821
Mar 201481311
Apr 201482819
May 2014122715
Jun 2014122314
Jul 2014122413
Aug 20142137
Sep 201482221
Oct 201411139
Nov 2014142715
Dec 20145296
Jan 2015132312
Feb 201510144
Mar 201511216
Apr 201510174
May 201510188
Jun 2015132518
Jul 201514295
Aug 20158135
Sep 201512118
Oct 201512293
Nov 201518315
Dec 201562110
Jan 201618188
Feb 201652114
Mar 201681920
Apr 2016141110
May 2016101917
Jun 20166129
Jul 20167108
Aug 20169115
Sep 20165125
Oct 20168165
Nov 201610156
Dec 201651512
Jan 20171201
Feb 2017091
Mar 20170226
Apr 201702012
May 201701221
Jun 201701718
Jul 201721029
Aug 20170814
Sep 201701338
Oct 201702215
Nov 201703117
Dec 20170368
Jan 201804110
Feb 201822617
Mar 201812219
Apr 201812121
May 201832320
Jun 201801715
Jul 20180125
Aug 20180126
Sep 20180189
Oct 201801413
Nov 201802218
Dec 2018642
Jan 20193326
Feb 20191703
Mar 2019501
Apr 20198111
May 20191602
Jun 2019926
Jul 2019351312
Aug 2019901
Sep 20191803
Oct 20192041
Nov 2019710
Dec 20191901
Jan 2020400
Feb 2020914
Mar 2020800
Apr 2020311
May 2020530
Jun 2020100
Jul 2020900
Aug 20201400
Sep 2020510
Oct 2020202
Nov 2020213
Dec 20201521
Jan 20211414
Feb 20211013
Mar 20211010
Apr 2021321
May 2021632
Jun 2021110
Jul 2021613
Aug 20211310
Sep 2021721
Oct 2021710
Nov 20211612
Dec 20211611
Jan 20222034
Feb 2022611
Mar 20221611
Apr 20221411
May 2022201
Jun 20221521
Jul 20221032
Aug 20221134
Sep 20221410
Oct 20221710
Nov 20221214
Dec 20221020
Jan 2023810
Feb 20231610
Mar 20231322

PreviousNext
Back to top

In this issue

Molecular Pharmacology: 72 (5)
Molecular Pharmacology
Vol. 72, Issue 5
1 Nov 2007
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

Noriyuki Nakatsu, Tomoki Nakamura, Kanami Yamazaki, Soutaro Sadahiro, Hiroyasu Makuuchi, Jun Kanno and Takao Yamori
Molecular Pharmacology November 1, 2007, 72 (5) 1171-1180; DOI: https://doi.org/10.1124/mol.107.038836

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Evaluation of Action Mechanisms of Toxic Chemicals Using JFCR39, a Panel of Human Cancer Cell Lines

Noriyuki Nakatsu, Tomoki Nakamura, Kanami Yamazaki, Soutaro Sadahiro, Hiroyasu Makuuchi, Jun Kanno and Takao Yamori
Molecular Pharmacology November 1, 2007, 72 (5) 1171-1180; DOI: https://doi.org/10.1124/mol.107.038836
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Mechanism of the selective action of paraherquamide A
  • Fatty Acid Amide Hydrolase in Cisplatin Nephrotoxicity
  • Use-Dependent Relief of A-887826 Inhibition
Show more Articles

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics